| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -32.25M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Year to date, EVMN has returned -18.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -18.1% |
| All-time high | $26.00 (Feb 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in EVMN would be worth today ›No. Evommune, Inc. has not paid a dividend in the past 12 months.
Evommune, Inc. stock trades on NYSE under the ticker symbol EVMN.
Evommune, Inc. is part of the Healthcare sector.
Evommune, Inc. has a market cap of 508.82M USD, based on the latest quote.
